312 related articles for article (PubMed ID: 25779662)
41. Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.
Li HY; Deng DH; Huang Y; Ye FH; Huang LL; Xiao Q; Zhang B; Ye BB; Lai YR; Mo ZN; Liu ZF
Eur J Haematol; 2015 May; 94(5):439-48. PubMed ID: 25227715
[TBL] [Abstract][Full Text] [Related]
42. High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia.
Fu L; Fu H; Qiao J; Pang Y; Xu K; Zhou L; Wu Q; Li Z; Ke X; Xu K; Shi J
Cancer Sci; 2017 Sep; 108(9):1850-1857. PubMed ID: 28670859
[TBL] [Abstract][Full Text] [Related]
43. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.
El Ghannam D; Taalab MM; Ghazy HF; Eneen AF
Blood Cells Mol Dis; 2014; 53(1-2):61-6. PubMed ID: 24512939
[TBL] [Abstract][Full Text] [Related]
44. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
45. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
46. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
Greif PA; Konstandin NP; Metzeler KH; Herold T; Pasalic Z; Ksienzyk B; Dufour A; Schneider F; Schneider S; Kakadia PM; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
Haematologica; 2012 Dec; 97(12):1909-15. PubMed ID: 22689681
[TBL] [Abstract][Full Text] [Related]
47. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
[TBL] [Abstract][Full Text] [Related]
48. High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions.
Fu L; Fu H; Wu Q; Pang Y; Xu K; Zhou L; Qiao J; Ke X; Xu K; Shi J
J Transl Med; 2017 Jul; 15(1):159. PubMed ID: 28724426
[TBL] [Abstract][Full Text] [Related]
49. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
Qian J; Lin J; Qian W; Ma JC; Qian SX; Li Y; Yang J; Li JY; Wang CZ; Chai HY; Chen XX; Deng ZQ
Leuk Res; 2013 Jul; 37(7):765-8. PubMed ID: 23582927
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ
Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537
[TBL] [Abstract][Full Text] [Related]
52. Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia.
Li Y; Lin J; Yang J; Qian J; Qian W; Yao DM; Deng ZQ; Liu Q; Chen XX; Xie D; An C; Tang CY
Leuk Res; 2013 Dec; 37(12):1642-7. PubMed ID: 24138945
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
[TBL] [Abstract][Full Text] [Related]
54. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
55. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
[TBL] [Abstract][Full Text] [Related]
56. Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia.
Ramsey JM; Kettyle LM; Sharpe DJ; Mulgrew NM; Dickson GJ; Bijl JJ; Austin P; Mayotte N; Cellot S; Lappin TR; Zhang SD; Mills KI; Krosl J; Sauvageau G; Thompson A
Stem Cells; 2013 Jul; 31(7):1434-45. PubMed ID: 23592435
[TBL] [Abstract][Full Text] [Related]
57. Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemia.
Haferlach C; Kern W; Schindela S; Kohlmann A; Alpermann T; Schnittger S; Haferlach T
Genes Chromosomes Cancer; 2012 Mar; 51(3):257-65. PubMed ID: 22072540
[TBL] [Abstract][Full Text] [Related]
58. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
59. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.
Marcucci G; Maharry KS; Metzeler KH; Volinia S; Wu YZ; Mrózek K; Nicolet D; Kohlschmidt J; Whitman SP; Mendler JH; Schwind S; Becker H; Eisfeld AK; Carroll AJ; Powell BL; Kolitz JE; Garzon R; Caligiuri MA; Stone RM; Bloomfield CD
J Clin Oncol; 2013 Jun; 31(17):2086-93. PubMed ID: 23650424
[TBL] [Abstract][Full Text] [Related]
60. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
